Get the Stockscreener App
5.50
6.75%
-0.398
Dermata Therapeutics Inc stock is traded at $5.50, with a volume of 47,412.
It is down -6.75% in the last 24 hours and down -22.09% over the past month.
Dermata Therapeutics Inc is a late-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its two product candidates, XYNGARI (formerly known as DMT310) and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Dermata announced positive Phase 3 data from its STAR-1 clinical trial in March 2025.
See More
Previous Close:
$5.898
Open:
$5.9
24h Volume:
47,412
Relative Volume:
2.49
Market Cap:
$3.75M
Revenue:
-
Net Income/Loss:
$-11.27M
P/E Ratio:
-0.2569
EPS:
-21.4132
Net Cash Flow:
$-9.40M
1W Performance:
+2.80%
1M Performance:
-22.09%
6M Performance:
-49.96%
1Y Performance:
-63.58%
1-Day Range:
$5.40
$5.93
1-Week Range:
$5.14
$5.93
52-Week Range:
$5.09
$24.90
Dermata Therapeutics Inc Stock (DRMA) Company Profile
Name
Dermata Therapeutics Inc
Sector
Industry
Phone
(858)-223-0882
Address
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Compare DRMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
5.50 | 3.94M | 0 | -11.27M | -9.40M | -21.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Dermata Therapeutics Inc Stock (DRMA) Latest News
Can Dermata Therapeutics Inc. Equity Warrant hit a new high this monthJuly 2025 Recap & Reliable Entry Point Trade Alerts - Newser
Using fundamentals and technicals on Dermata Therapeutics Inc.Forecast Cut & Long Hold Capital Preservation Tips - Newser
Can Dermata Therapeutics Inc. reach resistance levels soonJuly 2025 Setups & Daily Profit Focused Screening - khodrobank.com
Long term hold vs stop loss in Dermata Therapeutics Inc. Equity WarrantProduct Launch & Comprehensive Market Scan Reports - Newser
What is Dermata Therapeutics Inc. Equity Warrant’s market position2025 Earnings Impact & AI Forecasted Entry/Exit Points - khodrobank.com
Can Dermata Therapeutics Inc. rally from current levelsJuly 2025 Retail & Free High Return Stock Watch Alerts - Newser
Using AI based signals to follow Dermata Therapeutics Inc. Equity WarrantOptions Play & Fast Gain Stock Trading Tips - Newser
Is Dermata Therapeutics Inc. forming a reversal pattern2025 Technical Overview & Real-Time Buy Signal Alerts - Newser
How to escape a deep drawdown in Dermata Therapeutics Inc. Equity WarrantWeekly Stock Analysis & Real-Time Buy Zone Alerts - Newser
Understanding Dermata Therapeutics Inc.’s price movementJuly 2025 Movers & Daily Oversold Bounce Ideas - Newser
Will Dermata Therapeutics Inc. Equity Warrant announce a stock split2025 Year in Review & High Accuracy Investment Signals - khodrobank.com
Can machine learning forecast Dermata Therapeutics Inc. recoveryWeekly Stock Summary & Daily Technical Stock Forecast Reports - Newser
How high can Dermata Therapeutics Inc. stock go2025 Macro Impact & Consistent Income Trade Ideas - Newser
Is Dermata Therapeutics Inc. Equity Warrant a candidate for recovery play2025 Key Lessons & AI Forecasted Entry and Exit Points - Newser
Earnings Miss: What is Dermata Therapeutics Inc.’s market positionJuly 2025 Highlights & Verified Swing Trading Watchlist - khodrobank.com
Aug Gainers: Is Dermata Therapeutics Inc. Equity Warrant benefiting from innovation trendsJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - khodrobank.com
Can Dermata Therapeutics Inc. expand into new marketsEarnings Performance Report & Growth Oriented Trading Recommendations - khodrobank.com
How to recover losses in Dermata Therapeutics Inc. Equity Warrant stockShare Buyback & Growth Focused Stock Reports - Newser
Ranking Dermata Therapeutics Inc. Equity Warrant among high performing stocks via toolsPortfolio Value Report & Accurate Trade Setup Notifications - Newser
Insider Buy: What is Dermata Therapeutics Inc.’s market positionJuly 2025 Spike Watch & Daily Price Action Insights - khodrobank.com
Published on: 2025-09-03 09:17:06 - khodrobank.com
Predicting Dermata Therapeutics Inc. trend using moving averagesShort Setup & Smart Money Movement Alerts - Newser
Custom watchlist performance reports with Dermata Therapeutics Inc.2025 Volume Leaders & Free High Return Stock Watch Alerts - Newser
How to build a custom watchlist for Dermata Therapeutics Inc. Equity WarrantWeekly Stock Analysis & Risk Managed Investment Strategies - Newser
Key metrics from Dermata Therapeutics Inc.’s quarterly data2025 Earnings Impact & Technical Entry and Exit Tips - Newser
Technical analysis overview for Dermata Therapeutics Inc. stockQuarterly Portfolio Report & Safe Capital Growth Tips - Newser
Visual trend scoring systems applied to Dermata Therapeutics Inc.2025 Earnings Impact & Fast Moving Stock Watchlists - Newser
Will Dermata Therapeutics Inc. Equity Warrant outperform the marketWeekly Stock Report & Precise Buy Zone Identification - Newser
Using portfolio simulators with Dermata Therapeutics Inc. Equity Warrant includedJuly 2025 Final Week & High Accuracy Trade Signal Alerts - Newser
Tools to monitor Dermata Therapeutics Inc. Equity Warrant recovery probabilityDollar Strength & Safe Capital Growth Trade Ideas - Newser
Applying big data sentiment scoring on Dermata Therapeutics Inc.Analyst Upgrade & Smart Allocation Stock Tips - Newser
Leading vs lagging indicators on Dermata Therapeutics Inc. performanceWeekly Profit Report & Community Trade Idea Sharing - Newser
Published on: 2025-09-03 00:17:38 - Newser
Published on: 2025-09-02 23:38:57 - Newser
Tools to assess Dermata Therapeutics Inc. Equity Warrant’s risk profileEntry Point & High Return Trade Guides - Newser
Using RSI to spot recovery in Dermata Therapeutics Inc. Equity WarrantWeekly Loss Report & Real-Time Volume Analysis - Newser
Can Dermata Therapeutics Inc. Equity Warrant Rally Enough to Break EvenJuly 2025 Reactions & Fast Moving Market Watchlists - beatles.ru
Real time pattern detection on Dermata Therapeutics Inc. stockMarket Volume Report & High Win Rate Trade Alerts - Newser
Can technical indicators confirm Dermata Therapeutics Inc. Equity Warrant’s reversalExit Point & Weekly High Return Opportunities - Newser
What indicators show strength in Dermata Therapeutics Inc.July 2025 Momentum & Verified Momentum Watchlists - Newser
Is Fundamental Global Inc. forming a bottoming baseJuly 2025 Closing Moves & Real-Time Buy Zone Alerts - Newser
Sector ETF performance correlation with Dermata Therapeutics Inc.2025 Institutional Moves & Real-Time Volume Analysis - Newser
Is Dermata Therapeutics Inc.’s ROIC above industry averageJuly 2025 Update & Entry Point Confirmation Signals - khodrobank.com
Multi factor analysis applied to Dermata Therapeutics Inc. Equity WarrantMarket Movement Recap & Fast Entry Momentum Alerts - Newser
What to expect from Dermata Therapeutics Inc. in the next 30 daysJuly 2025 Rallies & Detailed Earnings Play Strategies - Newser
Visual trend scoring systems applied to Dermata Therapeutics Inc2025 Earnings Impact & Community Verified Swing Trade Signals - Newser
Can Dermata Therapeutics Inc. Equity Warrant stock double in the next yearPortfolio Value Report & Long-Term Safe Investment Ideas - khodrobank.com
Is Dermata Therapeutics Inc. Equity Warrant benefiting from innovation trendsQuarterly Investment Review & Verified Swing Trading Watchlist - khodrobank.com
How institutional ownership impacts Dermata Therapeutics Inc. stockPortfolio Update Summary & Free Fast Gain Swing Trade Alerts - Newser
Will Dermata Therapeutics Inc. Equity Warrant benefit from green energy policies2025 Breakouts & Breakdowns & Fast Moving Market Watchlists - khodrobank.com
Should I set a stop loss on Dermata Therapeutics Inc.July 2025 Update & Free Safe Entry Trade Signal Reports - khodrobank.com
Dermata Therapeutics Inc Stock (DRMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):